Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension

References

• Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–e526.
   PubMed Web of Science ®Google Scholar
• Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–1281.
   PubMed Web of Science ®Google Scholar
• Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–1909.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–1401.
   PubMed Web of Science ®Google Scholar
• Fadl Elmula FE, Jin Y, Yang WY, et al. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood Press. 2015;24:263–274.
   PubMed Web of Science ®Google Scholar
• Persu A, Jin Y, Azizi M, et al. Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens. 2014;28:150–156.
   PubMed Web of Science ®Google Scholar
• Persu A, Azizi M, Jin Y, et al. Hyperresponders vs. nonresponder patients after renal denervation: do they differ? J Hypertens. 2014;32:2422–2427.
   PubMed Web of Science ®Google Scholar
• Jin Y, Jacobs L, Baelen M, et al. Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial. Blood Press. 2014;23:138–146.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Am Med Ass. 2013;310:2191–2194.
   PubMed Web of Science ®Google Scholar
• British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular diseases in clinical practice. Heart. 2005;91:1–52.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
   PubMed Web of Science ®Google Scholar
• O'Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697–701.
   PubMed Web of Science ®Google Scholar
• O'Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–1768.
   PubMed Web of Science ®Google Scholar
• O'Brien E, Mee F, Atkins N, et al. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705 CP, Philips HP5332 and Nissei DS-175. Blood Press Monit. 1996;1:55–62.
   PubMedGoogle Scholar
• Franssen PML, Imholz BPM. Evaluation of the Mobil-O-Graph new generation ABPM device using the ESH criteria. Blood Press Monit. 2010;15:229–231.
   PubMed Web of Science ®Google Scholar
• Barna I, Keszei A, Dunai A. Evaluation of the Meditech ABPM-04 ambulatory blood pressure measuring device according to the British Hypertension Society protocol. Blood Press Monit. 1998;3:363–368.
   PubMedGoogle Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–2219.
   PubMed Web of Science ®Google Scholar
• Hernández-Hernández R, Armas de Hernández MJ, Armas-Padilla MC, et al. The effect of missing dose of enalapril versus amlodipine on ambulatory blood pressure. Blood Press Monit. 1996;1:121–126.
   PubMedGoogle Scholar
• Burnier M, Wuerzner G, Struijker-Boudier H, et al. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62:218–225.
   PubMed Web of Science ®Google Scholar
• Liu PS, Platt JF. CT angiography of the renal circulation. Radiol Clin North Am. 2010;48:347–365.
   PubMed Web of Science ®Google Scholar
• Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J. 2013;34:2132–2140.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–354.
   PubMed Web of Science ®Google Scholar
• Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich). 2012;14:429–434.
   PubMed Web of Science ®Google Scholar
• Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicilogical urine analysis. J Hypertens. 2013;31:766–774.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Ott C, Schmid A, et al. Adherence to antihypertensive medication in treatment-resistant hypertension undergoing renal denervation. J Am Heart Assoc. 2016;5:e002343.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Li Y, Hara A, et al. Blood pressure measurement Anno 2016. Am J Hypertens. 2017;30:453–463.
   PubMed Web of Science ®Google Scholar
• Persu A, Renkin J, Thijs L, et al. Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension. 2012;60:596–606.
   PubMed Web of Science ®Google Scholar
• Fadl Elmula FE, Feng Y, Jacobs L, et al. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis. Blood Press. 2017 [cited 2017 Apr 26]. DOI: 10.1080/08037051.2017.1311769
   Web of Science ®Google Scholar
• Desch S, Okon T, Heinemann D, et al. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension. 2015;62:1202–1208.
   Web of Science ®Google Scholar
• Mathiassen ON, Vase H, Bech JN, et al. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded trial 24-h blood pressure-based trial. J Hypertens. 2016;34:1639–1647.
   PubMed Web of Science ®Google Scholar
• Fadl Elmula FE, Hoffmann P, Larstorp AC, et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension. 2014;63:691–699.
   Web of Science ®Google Scholar
• Rosa J, Widimský P, Toušek P, et al. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Hypertension. 2014;65:407–413.
   PubMed Web of Science ®Google Scholar
• Azizi M, Sapoval M, Gosse P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385:1957–1965.
   PubMed Web of Science ®Google Scholar
• Kario K, Ogawa H, Okumura K, et al. SYMPLICITY HTN-Japan: first randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J. 2015;79:1222–1229.
   PubMed Web of Science ®Google Scholar
• Oliveras A, Armario P, Clarà A, et al. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study: a randomized controlled trial. J Hypertens. 2017;34:1863–1871.
   Web of Science ®Google Scholar
• Gifford RW. An algorithm for the management of resistant hypertension. Hypertension. 1988;11:171–175.
   Web of Science ®Google Scholar
• Berra E, Azizi M, Capron A, et al. Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension. Hypertension. 2016;68:297–306.
   PubMed Web of Science ®Google Scholar
• Pandey A, Raza F, Velasco A, et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment resistant hypertension. J Am Soc Hypertens. 2015;9:420–426.
   PubMed Web of Science ®Google Scholar
• Fadl Elmula FE, Hoffmann P, Fossum E, et al. Renal sympathetic denervation in patients with treatment-resitant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Hypertension. 2013;62:526–532.
   PubMed Web of Science ®Google Scholar
• Azizi M, Pereira H, Hamdidouche I, et al. Adherence to antihypertensive treatment and the blood pressure lowering effects of renal denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Circulation. 2016;134:847–857.
   PubMed Web of Science ®Google Scholar
• de Jager RL, de Beus E, Beeftink MMA, et al. The impact of medication adherence on the effect of renal denervation. The SYMPATHY trial. Hypertension. 2017;69:678–684.
   PubMed Web of Science ®Google Scholar
• Azizi M, Ménard J, Peyrard S, et al. Assessment of patients’ and physicians’ compliance to an ACE inhibitor treatment based on urinary N-Acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events and Ramipril (DIABHYCAR) study. Diabet Care. 2006;29:1331–1336.
   PubMed Web of Science ®Google Scholar
• Gal P, de Jong MR, Smit JJ, et al. Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study. J Hum Hypertens. 2015;29:292–295.
   PubMed Web of Science ®Google Scholar
• de Jong MR, Adiyaman A, Gal P, et al. Renal nerve stimulation-induced blood pressure changes predict ambulatory blood pressure response after renal denervation. Hypertension. 2016;68:707–714.
   PubMed Web of Science ®Google Scholar